secwatch.observer — SEC 8-K summary
======================================

Issuer:     JOINT Corp (JYNT)
CIK:        0001612630
Form:       8-K/A
Filed at:   2022-02-25T23:59:59+00:00
Accession:  0001171843-22-001345
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Joint Corp. reports 38% revenue growth in FY2021; corrects 2022 clinic opening guidance to 110-130
--------------------------------------------------------------------------------

- Q4 revenue $22.4M (+32% YoY); net income $224K vs $10.6M (prior year benefitted from $8.9M tax valuation allowance reversal).
- Full-year revenue $81.2M (+38%); Adjusted EBITDA $13.3M (+46%); system-wide comp sales +29%.
- Opened 130 clinics in 2021 (110 franchised, 20 greenfield); total clinics 706 at year-end.
- 2022 guidance: revenue $102-106M, Adjusted EBITDA $15-17M; franchised openings corrected to 110-130 from 130-140.
- Cash $19.5M at Dec 31, 2021; sold 156 franchise licenses in 2021 vs 121 in 2020.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322001345/0001171843-22-001345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1612630/000117184322001345/f8ka_022522.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-001345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer